We are live on ! Find out more
CCB

Cutter & Co Brokerage Portfolio holdings

AUM $423M
1-Year Est. Return 15.02%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$317M
AUM Growth
-$35.1M
Cap. Flow
-$43.5M
Cap. Flow %
-13.73%
Top 10 Hldgs %
25.51%
Holding
314
New
22
Increased
118
Reduced
119
Closed
12

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$38.6M
2
WMT icon
Walmart Inc
WMT
+$9.18M
3
VMI icon
Valmont Industries
VMI
+$1.61M
4
FMC icon
FMC
FMC
+$897K
5
SBRA icon
Sabra Healthcare REIT
SBRA
+$729K

Sector Composition

Rank Sector Weight
1 Energy 12.49%
2 Materials 11.11%
3 Healthcare 10.91%
4 Financials 9.67%
5 Utilities 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEI icon
76
HEICO Corp
HEI
$49.8B
$1.09M 0.34%
8,155
+285
+4% +$31.7K
MA icon
77
Mastercard
MA
$502B
$1.08M 0.34%
4,066
+458
+13% +$115K
PBA icon
78
Pembina Pipeline
PBA
$28.4B
$1.05M 0.33%
28,331
-257
-0.9% -$9.36K
ET icon
79
Energy Transfer Partners
ET
$70.1B
$1.02M 0.32%
72,803
+14,892
+26% +$220K
NVS icon
80
Novartis
NVS
$297B
$986K 0.31%
10,797
-2,799
-21% -$237K
ARCC icon
81
Ares Capital
ARCC
$13.5B
$972K 0.31%
54,181
-1,511
-3% -$26.7K
HXL icon
82
Hexcel
HXL
$7.79B
$972K 0.31%
12,017
+657
+6% +$47.8K
IQV icon
83
IQVIA
IQV
$38.7B
$962K 0.3%
5,980
FBT icon
84
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$901K 0.28%
6,395
+1,301
+26% +$180K
ROKU icon
85
Roku
ROKU
$21.5B
$896K 0.28%
9,890
-1,250
-11% -$100K
IYW icon
86
iShares US Technology ETF
IYW
$23.6B
$884K 0.28%
17,872
-1,324
-7% -$64.7K
LRCX icon
87
Lam Research
LRCX
$367B
$882K 0.28%
46,970
-190
-0.4% -$3.6K
CAT icon
88
Caterpillar
CAT
$375B
$868K 0.27%
6,370
+219
+4% +$28.9K
PGX icon
89
Invesco Preferred ETF
PGX
$3.81B
$863K 0.27%
58,999
-271
-0.5% -$3.96K
HD icon
90
Home Depot
HD
$331B
$861K 0.27%
4,142
+413
+11% +$82.4K
CSCO icon
91
Cisco
CSCO
$457B
$853K 0.27%
15,593
+361
+2% +$19.9K
PAA icon
92
Plains All American Pipeline
PAA
$17.3B
$835K 0.26%
34,292
+803
+2% +$19.2K
INTC icon
93
Intel
INTC
$455B
$826K 0.26%
17,249
-622
-3% -$30.8K
VEU icon
94
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$824K 0.26%
16,158
-924
-5% -$46.6K
TGT icon
95
Target
TGT
$65.6B
$800K 0.25%
9,242
+814
+10% +$65.8K
CSX icon
96
CSX Corp
CSX
$93.4B
$794K 0.25%
30,795
-900
-3% -$23.2K
NTUS
97
DELISTED
Natus Medical Inc
NTUS
$793K 0.25%
30,850
-100
-0.3% -$2.55K
BAC icon
98
Bank of America
BAC
$435B
$790K 0.25%
27,256
+289
+1% +$8.33K
WSO icon
99
Watsco Inc
WSO
$12.7B
$784K 0.25%
4,793
+648
+16% +$102K
GH icon
100
Guardant Health
GH
$21.7B
$756K 0.24%
8,760
+3,120
+55% +$238K

Similar funds

Cutter & Co Brokerage's Q2 2019 Portfolio in Review

As of Q2 2019, Cutter & Co Brokerage held 314 positions worth $317M, down 10% from $352M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cutter & Co Brokerage withdrew a net $43.5M in Q2 2019, closing 12 positions and reducing 119 holdings. Its most notable exit was Valmont Industries, an estimated $1.61M position sold in full.

By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 11% a quarter earlier, followed by Materials and Healthcare.

Against the trend, Cutter & Co Brokerage opened a new position in First Trust Health Care AlphaDEX Fund worth $714K.

  • Cutter & Co Brokerage's largest Q2 2019 buy was First Trust Health Care AlphaDEX Fund: 9,219 shares worth $714K.
  • Cutter & Co Brokerage added most to Livent Corporation in Q2 2019, an estimated $1.01M increase.
  • Cutter & Co Brokerage's biggest Q2 2019 reduction was Zoetis, cutting an estimated $38.6M.
  • Cutter & Co Brokerage fully exited Valmont Industries in Q2 2019, selling an estimated $1.61M.
  • Cutter & Co Brokerage's ten largest holdings make up 26% of its $317M portfolio in Q2 2019.
  • Cutter & Co Brokerage opened 22 new positions and closed 12 in Q2 2019.
  • Cutter & Co Brokerage's portfolio value fell 10% quarter-over-quarter to $317M.

Based on Cutter & Co Brokerage's 13F filing for Q2 2019, filed 31 Jul 2019.